EUVIMEDEUVIMED entdecken
Open Access

The epigenetic state of the cell of origin defines mechanisms of leukemogenesis

Zhiheng Li, Sara Fierstein iD, Mayuri Tanaka-Yano iD, Katie Frenis iD, Chun-Chin Chen, Dahai Wang, Marcelo Falchetti iD, Parker Côté, Christina Curran, Kate Lu, Tianxin Liu, Stuart Orkin und 5 weitere

Leukemia · 2025

DOI: 10.1038/s41375-024-02428-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Leukemia, 2025. Verfasst von Zhiheng Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Program and Stem Cell Transplantation Programs, Boston Children's Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Leukemia, Myeloid, Acute, Hematopoietic Stem Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, V Foundation for Cancer Research (V Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) shows variable clinical outcome. The normal hematopoietic cell of origin impacts the clinical behavior of AML, with AML from hematopoietic stem cells (HSCs) prone to chemotherapy resistance in model systems. However, the mechanisms by which HSC programs are transmitted to AML are not known. Here, we introduce the leukemogenic MLL-AF9 translocation into defined human hematopoietic populations, finding that AML from HSCs is enriched for leukemic stem cells (LSCs) compared to AML from progenitors. By epigenetic profiling, we identify a putative inherited program from the normal HSC that collaborates with oncogene-driven programs to confer aggressive behavior in HSC-AML. We find that components of this program are required for HSC-AML growth and survival and identify RNA polymerase (RNAP) II-mediated transcription as a therapeutic vulnerability. Overall, we propose a mechanism as to how epigenetic programs from the leukemic cell of origin are inherited through transformation to impart the clinical heterogeneity of AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticLeukemia, Myeloid, AcuteHematopoietic Stem CellsHumansOncogene Proteins, FusionMyeloid-Lymphoid Leukemia ProteinNeoplastic Stem CellsCell Transformation, NeoplasticAnimalsMiceCarcinogenesisGene Expression Regulation, Leukemic

Substanzen

Oncogene Proteins, FusionMyeloid-Lymphoid Leukemia ProteinMLL-AF9 fusion protein, human

Autor:innen und Institutionen

  • Stem Cell Program and Stem Cell Transplantation Programs, Boston Children's Hospital, Boston, MA, USA.
  • Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
  • Department of Hematology/Oncology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Federal University of Santa Catarina, Florianopolis, Brazil.
  • Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Howard Hughes Medical Institute, Boston, MA, USA.

ORCID-Profile: Sara Fierstein, Mayuri Tanaka-Yano, Katie Frenis, Marcelo Falchetti, Edroaldo Lummertz da Rocha, Shaoyan Hu, Qian Zhu, R Grant Rowe

Förderung

  • NIDDK NIH HHS
  • V Foundation for Cancer Research (V Foundation)

Zitieren

APA

Li, Z., Fierstein, S., Tanaka-Yano, M., Frenis, K., Chen, C. C., Wang, D., Falchetti, M., Côté, P., Curran, C., Lu, K., Liu, T., Orkin, S., Li, H., Lummertz da Rocha, E., Hu, S., Zhu, Q., & Rowe, R. G. (2025). The epigenetic state of the cell of origin defines mechanisms of leukemogenesis. Leukemia. https://doi.org/10.1038/s41375-024-02428-y

Vancouver

Li Z, Fierstein S, Tanaka-Yano M, Frenis K, Chen CC, Wang D, et al. The epigenetic state of the cell of origin defines mechanisms of leukemogenesis. Leukemia. 2025. doi:10.1038/s41375-024-02428-y

BibTeX
@article{Li2025,
  author = {Li, Zhiheng and Fierstein, Sara and Tanaka-Yano, Mayuri and Frenis, Katie and Chen, Chun-Chin and Wang, Dahai and Falchetti, Marcelo and Côté, Parker and Curran, Christina and Lu, Kate and Liu, Tianxin and Orkin, Stuart and Li, Hojun and Lummertz da Rocha, Edroaldo and Hu, Shaoyan and Zhu, Qian and Rowe, R Grant},
  title = {The epigenetic state of the cell of origin defines mechanisms of leukemogenesis},
  journal = {Leukemia},
  year = {2025},
  doi = {10.1038/s41375-024-02428-y}
}
Kostenlos starten →